THE CODE: The Code is a three-part video series investigating the roots of today’s most promising genetic technologies
By Text: Sharon Begley Video: Retro Report,
STAT
| 04. 02. 2018
Those who do not remember the past are doomed to repeat it. And those who do not remember the sometimes irrational exuberance around past advances in biomedicine may be doomed to buy into the hype around today’s. From curing Alzheimer’s and Parkinson’s to eliminating cancer deaths, no goal has been too ambitious for the best minds in medicine to claim is within reach thanks to the latest scientific discovery.
Here is your genetic gut check.
This three-part series of documentary shorts, produced by Retro Report in partnership with STAT, looks back at the roots of three of today’s most promising genetic technologies: genetic testing to predict which diseases someone might develop, precision medicine to match people’s genes to the treatments most likely to work for them, and genome-editing via CRISPR to repair disease-causing genes. Watch and listen to experts explain how the 1980s and 1990s version of each was going to change medicine and save lives. It puts today’s promises in a whole new light.
PART 1

The race to sequence the human genome was also billed as a race...
Related Articles
By Hannah Devlin, The Guardian | 07.05.2025
Scientists are just a few years from creating viable human sex cells in the lab, according to an internationally renowned pioneer of the field, who says the advance could open up biology-defying possibilities for reproduction.
Speaking to the Guardian, Prof...
By Maoli Duan, The Conversation | 07.02.2025
By Alice Park, TIME | 07.08.2025
Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to appear soon after birth.
To date, there haven’t been many reliable treatment options for these babies. The few that do exist involve...
By Jessica Hamzelou, MIT Technology Review | 07.18.2025
This week we heard that eight babies have been born in the UK following an experimental form of IVF that involves DNA from three people. The approach was used to prevent women with genetic mutations from passing mitochondrial diseases to...